Clinical Trial Update: Tachikawa Project for Prevention of Posttraumatic Stress Disorder With Polyunsaturated Fatty Acid (TPOP): TPOP-02 Study [Phase 3]

View source ↗

Summary

Phase 3 trial evaluated whether polyunsaturated fatty acid supplementation could prevent posttraumatic stress disorder after trauma exposure; the study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Polyunsaturated fatty acids (PUFA) supplementation (polyunsaturated fatty acids)

Snippet

Sponsor: Japan Science and Technology Agency | Conditions: Trauma, Posttraumatic Stress Disorder | Phase 3 | Status: COMPLETED